# Fimasartan Blood Pressure Lowering After Acute Stroke

> **NCT03231293** · — · COMPLETED · sponsor: **Boryung Pharmaceutical Co., Ltd** · enrollment: 1035 (actual)

## Conditions studied

- Hypertension
- Ischemic Stroke
- Transient Ischemic Attack

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03231293
- **Lead sponsor:** Boryung Pharmaceutical Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07-28
- **Primary completion:** 2018-11-02
- **Final completion:** 2019-04-05
- **Target enrollment:** 1035 (ACTUAL)
- **Last updated:** 2019-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03231293

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03231293, "Fimasartan Blood Pressure Lowering After Acute Stroke". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03231293. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*